Revisit Sebia’s Educational Webinar on HbA1c Utilisation: Key Insights from Updated Lab Guidelines
We are excited to invite you to revisit Sebia’s educational webinar, “To See or Not A1c? HbA1c Utilization in Light of Recent Lab Guidelines,” presented by Dr. Matthew C. Wagner, Scientific Affairs Specialist at Sebia. This webinar is a must-watch for laboratory professionals and clinicians involved in diabetes care and management.
Why This Webinar Matters
The American Association of Clinical Chemistry (AACC), now known as the Association of Diagnostics & Laboratory Medicine (ADLM), in collaboration with the American Diabetes Association (ADA), has released updated guidelines for the laboratory analysis of HbA1c. These guidelines are crucial for improving the accuracy and reliability of diabetes diagnosis and management.
Key Takeaways from the Webinar
- Updated Guidelines: Dr. Wagner discusses the latest evidence-based recommendations for HbA1c testing, highlighting significant changes from previous guidelines. These updates aim to enhance the precision of diabetes diagnosis and monitoring, ensuring better patient outcomes.
- Best Practices: Learn about the standard uses and best practices for HbA1c testing in clinical laboratories. Dr. Wagner provides insights into how laboratories can implement these practices to meet the new guidelines effectively.
- Identifying Discordance: The webinar covers scenarios where HbA1c results may not be appropriate and how to identify such discordance. Dr. Wagner explains alternative testing methods that can be used in these situations to ensure accurate diagnosis and monitoring.
- Analytical Solutions: Discover the analytical solutions that Sebia offers to help laboratories meet the updated recommendations while managing the demands of HbA1c testing. These solutions are designed to improve efficiency and accuracy in the lab.
Why You Should Watch
Revisiting this webinar will provide you with valuable knowledge and practical tips to enhance your laboratory’s HbA1c testing capabilities. Staying updated with the latest guidelines is essential for delivering high-quality patient care and ensuring the reliability of diabetes management.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
